Çağlayan, D. Et Al. 2022. The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.. European journal of clinical pharmacology .

Çağlayan, D., Koçak, M. Z., Geredeli, Ç., Tatlı, A. M., Göksu, S. S., Eryılmaz, M. K., ... Araz, M.(2022). The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.. European journal of clinical pharmacology .

Çağlayan, Dilek Et Al. "The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.," European journal of clinical pharmacology , 2022

Çağlayan, Dilek Et Al. "The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.." European journal of clinical pharmacology , 2022

Çağlayan, D. Et Al. (2022) . "The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.." European journal of clinical pharmacology .

@article{article, author={Dilek Çağlayan Et Al. }, title={The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.}, journal={European journal of clinical pharmacology}, year=2022}